Osprey Medical gets FDA OK for angiogram device

08/26/2013 | BioSpectrum Asia

Osprey Medical has been cleared by the FDA to market its Avert System, which is used to minimize patient exposure to dye during angiogram or diagnostic heart procedures. A clinical study showed the device was able to lower by as much as 40% the amount of dye used during angiograms while maintaining image quality.

View Full Article in:

BioSpectrum Asia

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN